PP
ELV icon

Pacifica Partners’s Elevance Health ELV Stock Holding History

Pacifica Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5
Closed -$2.26K – 531
2025
Q1 		$2.26K Buy
+5
New +$2.01K ﹤0.01% 443
2022
Q4 		– Sell
-13
Closed -$6K – 475
2022
Q3 		$6K Buy
+13
New +$6.22K ﹤0.01% 347

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Pacifica Partners's ELV Position: Q2 2025 in Review

Pacifica Partners sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 5 shares — an estimated $2.26K sold.

Pacifica Partners first reported a position in ELV in Q3 2022 and held it in 2 quarters. The position peaked at $6K in Q3 2022. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Pacifica Partners reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Pacifica Partners sold 5 Elevance Health shares in Q2 2025, an estimated $2.26K.
  • Pacifica Partners first reported a position in Elevance Health in Q3 2022 and held it in 2 quarters.
  • Pacifica Partners's Elevance Health position peaked at $6K in Q3 2022.
  • 1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Pacifica Partners's 13F filing for Q2 2025, filed 14 Jul 2025.